The James Lab focuses on translational ovarian and triple negative breast cancer research. Our overarching mission is to uncover novel immune based prognostic and therapeutic markers that can ultimately improve patient immunotherapy response. To accomplish this goal, we implement a variety of preclinical in vitro and in vivo models, including the utilization of patient samples to enhance the clinical relevance of our research.